Ankylosing Spondylitis
An inflammatory disease of the spine and sacroiliac joints causing chronic back pain, morning stiffness, and eventual fusion of the vertebrae, primarily affecting young HLA-B27 positive males.
Emergency Management: Cervical spine fracture. The ankylosed spine breaks like a long bone; these fractures are highly unstable and can cause catastrophic spinal cord injury or epidural hematoma. Requires rigid cervical collar and urgent neurosurgical intervention.
Ankylosing Spondylitis (AS) is a chronic, progressive inflammatory arthritis belonging to the seronegative spondyloarthropathies. It primarily targets the axial skeleton, starting at the sacroiliac (SI) joints and progressing cranially up the spine. Chronic inflammation leads to characteristic enthesitis, osteitis, and eventual bony fusion (ankylosis) of the spinal column.
Detailed Overview
AS typically affects young men in their 20s and 30s. The disease is strongly associated with the HLA-B27 genotype, though environmental triggers like gut dysbiosis or biomechanical stress are believed to initiate the aberrant immune response. The inflammation localizes to the entheses (where tendons and ligaments insert into bone). Over time, the body's repair mechanisms replace inflamed tissue with bone (syndesmophytes), ultimately fusing the spine into a rigid 'bamboo spine'. Extra-articular manifestations, particularly anterior uveitis, are common and can cause severe morbidity.
Epidemiology & Demographics
Prevalence is roughly 0.1% to 0.5% in the general population. Males are affected 2-3 times more frequently than females. Peak age of symptom onset is 20-30 years; it is rarely diagnosed after age 45.
Etiological Mechanism
The exact etiology is autoimmune and multifactorial. The genetic hallmark is the HLA-B27 allele, present in 85-90% of affected patients. The 'arthritogenic peptide' and 'unfolded protein response' hypotheses suggest aberrant immune targeting of joint tissue.
Primary Causes
Triggered by a combination of HLA-B27 genetic predisposition and potential environmental factors such as mechanical stress at entheses or microbiome alterations (e.g., Klebsiella infections).
Inflammation originates at the subchondral bone of the SI joints and the entheses of the spinal ligaments (enthesitis). Cytokines, heavily driven by TNF-alpha and IL-17, promote an erosive osteitis. Following erosion, aberrant osteoblast activation leads to heterotopic bone formation. Progressive ossification of the annulus fibrosus forms bridging syndesmophytes between adjacent vertebral bodies, resulting in complete spinal fusion.
Diagnostic Criteria & Guidelines
ASAS criteria for inflammatory back pain: Onset before age 40, insidious onset, improvement with exercise, no improvement with rest, pain at night. Diagnosis requires radiographic evidence of sacroiliitis PLUS at least one clinical feature of SpA, OR HLA-B27 positivity with at least two clinical features.
Continuous use of NSAIDs is the cornerstone of therapy (e.g., Naproxen 500 mg PO BID, Celecoxib 200 mg PO daily, or Indomethacin 50 mg PO TID). NSAIDs not only control pain but may also slow radiographic progression. Coupled with aggressive physical therapy for posture and spinal extension exercises.
Second-Line & Adjunctive Therapy
For persistently high disease activity despite maximum NSAID therapy, biologic DMARDs are indicated. TNF inhibitors (Adalimumab 40 mg SQ every 2 weeks, Etanercept 50 mg SQ weekly) or IL-17 inhibitors (Secukinumab 150 mg SQ every 4 weeks). Conventional synthetic DMARDs (Methotrexate, Sulfasalazine) are ineffective for axial disease but may be used for peripheral joint involvement.
Surgical & Procedural Management
Total Hip Arthroplasty (THA) for severe, debilitating hip joint arthritis. Spinal wedge osteotomy is rarely performed to correct severe fixed kyphosis allowing the patient to look forward.
Patient Counseling & Advice
Educate the patient on the importance of maintaining an upright posture. Explain that any minor trauma (e.g., falling, minor car accident) requires immediate medical evaluation to rule out cervical spine fractures.
Follow-Up & Monitoring Schedule
Assess disease activity every 3-6 months using the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and ASDAS. Annual spinal X-rays to monitor structural progression. DEXA scans to monitor for secondary osteoporosis.
Preventive Strategies
No prevention for disease onset. Prevention of deformity relies entirely on early initiation of TNF/IL-17 inhibitors and lifelong adherence to physical therapy.
Lifespan is generally normal, though morbidity can be high. Early treatment with biologics halts progression in many. Poor prognostic indicators include onset < 16 years, persistent systemic inflammation, and early hip involvement.